ClinicalTrials.Veeva

Menu

Effects of Obesity on Rectus Femoris Muscle Thickness, Sarcopenia, Gait and Balance in Women

K

Kutahya Health Sciences University

Status

Invitation-only

Conditions

Sarcopenic Obesity
Obesity
Sarcopenia

Treatments

Diagnostic Test: Ultrasonografi, Sarcopenia measurement, Zebris

Study type

Observational

Funder types

Other

Identifiers

NCT05638035
DSA2022

Details and patient eligibility

About

Research; It is a planned, non-invasive, controlled study in obese female volunteers and non-obese female volunteers. The population of the study consists of voluntarily non-obese women and obese women. Sarcopenia assets of individuals will be measured with the sarc-f questionnaire, and then muscle strength, muscle mass and physical performance tests will be measured. Then, rectus femoris muscle thickness will be measured with USG, and then walking and balance will be measured with ZEBRIS.

Enrollment

1 estimated patient

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Being over 18 years old and female
  • Volunteering and accepting to participate in the study
  • BMI 30-39.9 kg/m2 in obese women (experimental group)
  • BMI 18-27.9 kg/m2 in non-obese women (control group)
  • Not having cardiorespiratory, neurological, orthopedic and metabolic disorders

Exclusion criteria

  • Being under 18 years old and male
  • Having a BMI of 40.0 kg/m2 and above in obese women (experimental group)
  • BMI 28.0 kg/m2 and above in non-obese women (control group)
  • Having cardiorespiratory, neurological, orthopedic and metabolic disorders

Trial design

1 participants in 2 patient groups

non-obese women
Description:
After obtaining demographic information for women with a BMI of 18-27.9 kg/m2 for at least 6 months, Body Mass Index (BMI) will be calculated and the relationship between rectus femoris muscle thickness, sarcopenia, gait and balance will be evaluated and will be compared with obese group.
Treatment:
Diagnostic Test: Ultrasonografi, Sarcopenia measurement, Zebris
obese women
Description:
After obtaining demographic information in women with a BMI of 30-39.9 kg/m2, Body Mass Index (BMI) will be calculated and the relationship between obesity and rectus femoris muscle thickness, sarcopenia, gait and balance will be evaluated.
Treatment:
Diagnostic Test: Ultrasonografi, Sarcopenia measurement, Zebris

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems